A method for evaluating the effect of NK cells against cytomegalovirus
A cytomegalovirus and NK cell technology, applied in the field of evaluating the anti-cytomegalovirus effect of NK cells, can solve problems such as unknown and lack of systematic evaluation methods
Active Publication Date: 2022-02-15
PEOPLES HOSPITAL PEKING UNIV
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, it is unknown whether NK cells expanded in vitro have anti-CMV effects
[0005] Therefore, in this field, there is a lack of systematic assessment of whether NK cells have an anti-CMV effect; what is more, it is unknown whether NK cells expanded in vitro have an anti-CMV effect
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0079] Embodiment 1 (this embodiment is based on the evaluation system provided by the present invention, the specific operation process of implementation)
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention provides a system for evaluating the anti-cytomegalovirus effect of NK cells, the system comprising: a first evaluation subsystem for evaluating the anti-cytomegalovirus function of NK cells; a second evaluation subsystem for evaluating NK cells The function of cells to inhibit the expansion of cytomegalovirus; the third evaluation subsystem is used to evaluate the reinfectivity of cytomegalovirus after being acted on by NK cells; the fourth evaluation subsystem is used to evaluate the clearance of cytomegalovirus by NK cells Function. Through the system provided by the present invention, the anti-cytomegalovirus effect of natural killer cells (NK cells) is scientifically and normatively evaluated, and a scientific and systematic reference is provided for the application of natural killer cells in anti-cytomegalovirus. Accordingly, the system provided by the present invention has broad application prospects.
Description
technical field [0001] The invention belongs to the field of medical and biological detection, in particular to a method for evaluating the anti-cytomegalovirus effect of NK cells. Background technique [0002] Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and even the only way to cure malignant hematological diseases. Infection is the most common complication after allo-HSCT, accounting for nearly 50% of transplant-related deaths. After Allo-HSCT, the number and function of immune cells have not been restored to normal levels in the early stage, and infection is very prone to occur. Among them, cytomegalovirus (CMV) infection became the main cause of death after Allo-HSCT. The incidence of CMV infection after transplantation is as high as 30-80%, and can cause GVHD and bacterial or fungal infection, increase the risk of transplant-related death, and lead to poor transplant outcomes. The preventive and therapeutic effects of antiviral drug...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/0783
CPCG01N33/68G01N33/6866G01N33/5005C12Q1/705C12Q1/686C12Q2561/113C12Q2563/107C12Q2545/114
Inventor 黄晓军赵翔宇商倩楠余星星
Owner PEOPLES HOSPITAL PEKING UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com